Nutex Health Inc. (NUTX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on October 20, 2025, by Nutex Health Inc., a Delaware corporation headquartered in Houston, Texas. The filing addresses two primary matters: the issuance of a press release containing anticipated preliminary financial metrics for the period ended September 30, 2025, and a notice regarding the Company's compliance status with Nasdaq listing requirements.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing anticipated preliminary financial metrics for the period ended September 30, 2025. However, the text of this Form 8-K does not disclose specific values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the information in the press release is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Material Changes and Listing Status
A material development concerns the Company's compliance with Nasdaq Listing Rule 5250(c)(1). On August 20, 2025, Nasdaq notified the Company of its failure to timely file the Quarterly Report on Form 10-Q for the period ended June 30, 2025. In response, the Company submitted a compliance plan on October 15, 2025, requesting an extension to file the delinquent report by December 12, 2025. Nasdaq granted this extension on October 16, 2025.
Outlook, Risks, and Contingencies
The primary risk identified is the potential delisting from The Nasdaq Stock Market LLC. If the Company fails to file the June 30, 2025 Form 10-Q by the extended deadline of December 12, 2025, Nasdaq staff will issue a delisting notice. The Company retains the right to appeal such a notice to a Nasdaq Hearings Panel. No specific forward-looking guidance or management commentary regarding future financial performance is provided within the text of this filing.
Investor Verification Checklist
- Verify the specific preliminary financial metrics for the period ended September 30, 2025, by reviewing Exhibit 99.1 (Press Release) attached to this filing.
- Confirm the filing status of the delinquent Form 10-Q for the period ended June 30, 2025, before the December 12, 2025 deadline.
- Monitor Nasdaq announcements for any subsequent delisting notices or appeals following the December 12, 2025 deadline.
- Review the Company's liquidity position and ability to fund operations given the delay in financial reporting.